South Miami Hospital agreed to pay the federal government approximately $12 million to settle allegations that it violated the False Claims Act by submitting false claims for medically unnecessary cardiac procedures performed by John R. Dylewski, MD.

The Column Group has provided $50 million in Series A financing for a new company called Tenaya Therapeutics, which plans on focusing on regenerative medicine and developing medications to treat heart failure.

The federal government sued the owner of a diagnostic testing company for allegedly submitting false claims to Medicare. The complaint also alleges a cardiologist took part in the scheme, but he was not sued.

Seven researchers received more than $1 million in total from the American Heart Association (AHA) and the Children’s Heart Foundation for congenital heart defect research.

President-elect Donald Trump has named Cleveland Clinic CEO Toby Cosgrove to join a non-partisan panel of 16 business leaders whop will advise Trump on how government affects job and economic growth.

Boston Scientific has agreed to acquire a 15 percent equity stake in Neovasc, as well as the company’s advanced biological tissue business for $75 million in cash.

During the past few years, payers have shifted away from fee-for-service payment models and started holding clinicians more responsible for collaborating, keeping costs down and improving the quality of care. A recent review suggests that early adopters of the alternative payment models could benefit in the future when the models become more popular and penalties increase.

Edwards Lifesciences has agreed to acquire Valtech Cardio in a cash and stock deal valued at $340 million at closing, which is expected early next year.